PSTV

#4454
PLUS THERAPEUTICS, Inc. Common Stock
5.43 USD
+0.37%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
5.43
5.43
Intervallo Annuale
0.13
5.72
Variazione giornaliera
+0.37%
Variazione Mensile
+1911.11%
Variazione di 6 mesi
+664.79%
Variazione Annuale
+686.96%
Chiusura Precedente
5.41
Apertura
5.43
Bid
Ask
Minimo
5.43
High
5.43
Volume
13
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 37.26 M
  • Employee 28
  • Founded 1996
  • CEO N/A
  • Website www.plustherapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG000C1Z086
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.77
Rapporto prezzo/fatturato
7.65

PLUS THERAPEUTICS Inc

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

Notizie